Real-World Evidence Needs for Treatment Sequence Disease Modelling in Refractory Inflammatory Bowel Disease

被引：0
|
作者：
Kodjamanova, P. [1 ]
Sanon, M. [2 ]
Dimova, M. [3 ]
Wu, E. [2 ]
Atanasov, P. [4 ]
机构：
[1] Amaris Consulting, Real World Evidence, London, England
[2] Janssen Global Serv, Global Market Access, Raritan, NJ USA
[3] Janssen Global Serv, HTA Modelling, Horsham, PA USA
[4] Amaris Consulting, Real World Evidence, Barcelona, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1437
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1263
引用
收藏
页码：i2288 / i2288
页数：1
相关论文
共 50 条
  • [31] Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey
    Burisch, Johan
    Hart, Ailsa
    Sturm, Andreas
    Rudolph, Christine
    Meadows, Rachael
    Jus, Anna
    Dawod, Fatima
    Patel, Haridarshan
    Armuzzi, Alessandro
    INFLAMMATORY BOWEL DISEASES, 2024, 31 (02) : 411 - 424
  • [32] Treatment persistence and clinical outcomes of vedolizumab in inflammatory bowel disease patients in Taiwan: real-world evidence from the TSIBD registry
    Tai, Wei-Chen
    Tu, Chia-Hung
    Chou, Jen-Wei
    Feng, I-Che
    Chung, Chen-Shuan
    Shieh, Ming-Jium
    Yen, Hsu-Heng
    Hsu, Wen-Hung
    Lu, Chien-Yu
    Lu, Lung-Sheng
    Tang, Shu-Lun
    Lien, Pei-Wen
    Ye, Yizhou
    Dolin, Paul
    Wei, Shu-Chen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 305 - 305
  • [33] Adalimumab Persistence and Its Biosimilar in Inflammatory Bowel Disease: A Real-World Study
    Fernandez-Cano, Maria Carmen
    Fernandez-Cano, Antonio Jesus
    Martin-Rodriguez, Maria Mar
    Sanchez-Capilla, Antonio Damian
    Cabello-Tapia, Maria Jose
    Redondo-Cerezo, Eduardo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [34] Osteoporosis, osteopenia, and inflammatory bowel disease: lessons from a real-world study
    Pellicano, Rinaldo
    Ribaldone, Davide G.
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (7-8): : 411 - 413
  • [35] REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Mosli, Mahmoud
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward V., Jr.
    GASTROENTEROLOGY, 2018, 154 (01) : S82 - S82
  • [36] Real-world outcomes of vedolizumab for inflammatory bowel disease post liver transplantation
    Peverelle, M. a
    Mills, C.
    Testro, A.
    de Cruz, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S356 - S357
  • [37] Informed consent in inflammatory bowel disease: a necessity in real-world clinical practice
    Kyriakos, Nikolaos
    Papaefthymiou, Apostolis
    Giakoumis, Marios
    Iatropoulos, George
    Mantzaris, Gerasimos
    Liatsos, Christos
    ANNALS OF GASTROENTEROLOGY, 2021, 34 (04): : 466 - 475
  • [38] Pregnancy in Inflammatory Bowel Disease: Data from a Real-World Cohort in Germany
    Ayoub, Mousa
    Muzalyova, Anna
    Ebigbo, Alanna
    Nagl, Sandra
    Roemmele, Christoph
    Classen, Johanna
    Wanzl, Julia
    Fleischmann, Carola
    Ayoub, Sami
    Tadic, Vidan
    Schlottmann, Jakob
    Schnoy, Elisabeth
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (24)
  • [39] Real-world use of faecal calprotectin testing in patients with inflammatory bowel disease
    Rubin, D. T.
    Yang, M.
    Wu, E. Q.
    Skup, M.
    Lee, W. -J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S162 - S163
  • [40] Pathogenesis of Inflammatory Bowel Disease: Basic Science in the Light of Real-World Epidemiology
    Ribaldone, Davide Giuseppe
    Pellicano, Rinaldo
    Actis, Giovanni C.
    GASTROINTESTINAL DISORDERS, 2019, 1 (01): : 129 - 146
12345